Prevention & Lipids
Statin therapy
Statin efficacy, safety, and optimal intensity
Unknown pathwayAlso known as: statins, HMG-CoA reductase inhibitors
714
Clinical questions
9
Evidence-backed
0
Claims analyzed
Prevention & Lipids
Statin efficacy, safety, and optimal intensity
Synthesized from 9 evidence-backed clinical questions linked to this topic — 1 supporting the intervention, 3 against the intervention.
Does atorvastatin vs placebo improve outcomes in Decompensated cirrhosis of liver?
Low Certainty+ Favors benefitatorvastatin vs placebo
5 studies (108 patients, 1 RCTs) provide low-certainty evidence for benefit of atorvastatin for the outcome in Decompensated cirrhosis of liver.
Does bio-statin vs placebo improve outcomes in Graft failure?
Low Certainty− Favors harmbio-statin vs placebo · Left Ventricular Ejection Fraction
47 studies (1,241,474 patients) provide low-certainty evidence against benefit of bio-statin for Left Ventricular Ejection Fraction in Graft failure.
Does aspirin vs statin improve outcomes in FH: premature coronary heart disease?
Low Certainty− Favors harmaspirin vs statin · Cardiac Output
4 studies (5,032 patients) provide low-certainty evidence against benefit of aspirin for Cardiac Output in FH: premature coronary heart disease.
Does statin vs rosuvastatin improve outcomes in Malignant neoplasm of breast?
Low Certainty− Favors harmstatin vs rosuvastatin · Cardiac Index
3 studies (4,443 patients) provide low-certainty evidence against benefit of statin for Cardiac Index in Malignant neoplasm of breast.
No claims extracted for this topic
Specific, answerable questions in this area — each with its own synthesized evidence and consensus. Open one to see the forest plot, source trials, and how the consensus has changed over time.
Does bio-statin vs placebo improve outcomes in Graft failure?
Low Certainty− Favors harmbio-statin vs placebo · Left Ventricular Ejection Fraction
Does aspirin vs statin improve outcomes in FH: premature coronary heart disease?
Low Certainty− Favors harmaspirin vs statin · Cardiac Output
Questions where the synthesized consensus has shifted as new trials were indexed.
Targeting HDL-cholesterol to reduce residual cardiovascular risk
Current Opinion in Lipidology — Iacob A — Mar 2012
The beneficial effects of raising high-density lipoprotein cholesterol depends upon achieved levels of low-density lipoprotein cholesterol during statin therapy: Implications for coronary atheroma progression and cardiovascular events
European Journal of Preventive Cardiology — Puri R — Feb 2015
Patients with coronary artery disease and diabetes need improved management: a report from the EUROASPIRE IV survey: a registry from the EuroObservational Research Programme of the European Society of Cardiology
Cardiovascular Diabetology — Gyberg V — Oct 2015
Association of β-blocker therapy with long-term clinical outcomes in patients with coronary chronic total occlusion
Medicine — Hwang J — Jul 2016
Follow this topic to get a weekly “what changed” evidence digest and alerts when journal clubs schedule sessions on it.
Statin therapy (also known as statins, HMG-CoA reductase inhibitors). Statin efficacy, safety, and optimal intensity
Synapse tracks 3 specific clinical questions in Statin therapy, each synthesized independently from its own trial evidence. They include: "Does bio-statin vs placebo improve outcomes in Graft failure?"; "Does aspirin vs statin improve outcomes in FH: premature coronary heart disease?"; "Does statin vs rosuvastatin improve outcomes in Malignant neoplasm of breast?".
As of 2026-08-15, the scientific consensus on Statin therapy is unknown. No claims extracted for this topic
This evidence brief synthesizes Synapse's enriched cardiology corpus; cite as synapsesocial.com/topics/statin-therapy.
Deterministic synthesis from Synapse's enriched corpus — 94 words. No AI-generated novel content; every figure is sourced from the underlying paper, guideline, or trial record linked on this page.
Explore every Statin therapy paper on Synapse with AI-enriched clinical evidence, PICO analysis, and methodology classification.
Search Statin therapy papersPowered by Synapse — AI-enriched analysis of 600,000+ peer-reviewed papers
Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management
European Heart Journal — Stroes E — Feb 2015